Listing Compliance. The Company complies with all requirements of the NASDAQ Capital Market and shall cause the Shares and the Warrant Shares to be approved for listing on the NASDAQ Capital Market on the Closing Date.
Appears in 3 contracts
Samples: Placement Agency Agreement (PLx Pharma Inc.), Placement Agency Agreement (Ziopharm Oncology Inc), www.sec.gov
Listing Compliance. The Company complies with all requirements of the The NASDAQ Capital Stock Market and shall cause the Shares and the Warrant Shares to be approved for listing on the The NASDAQ Capital Stock Market on the Closing Date. The issuance and sale of the Shares and Warrants hereunder does not contravene the rules and regulations of the NASDAQ Stock Exchange as of the Closing Date.
Appears in 2 contracts
Samples: Purchase Agreement (HealthCare Ventures IX, L.P.), Purchase Agreement (Leap Therapeutics, Inc.)
Listing Compliance. The Company complies with all requirements of the NASDAQ Capital Market Stock Exchange and shall cause the Shares and the Warrant Shares to be approved for listing on the NASDAQ Capital Market Stock Exchange on the Closing Date. The issuance and sale of the Shares and Warrants hereunder does not contravene the rules and regulations of the NASDAQ Stock Exchange as of the Closing Date.
Appears in 1 contract
Samples: Placement Agency Agreement (Leap Therapeutics, Inc.)
Listing Compliance. The Company complies with all requirements of the NASDAQ Capital Market and shall cause the Shares and the Warrant Shares to be approved for listing on the NASDAQ Capital Market on the Closing Date.
Appears in 1 contract
